Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Illinois
| Provider | Medicare | Services |
|---|---|---|
| Cardiac Imaging Inc | $697.65 | 16.2K |
| Cusick, David M.D. | $405.57 | 1.9K |
| Stephan, William MD | $405.79 | 1.0K |
| Aziz, George M.D. | $405.85 | 938 |
| Zaidi, Ali MD | $413.51 | 754 |
| Rifai, Luay | $410.75 | 651 |
| Balek, Mark M.D. | $425.48 | 622 |
| Reddy, Sora M.D. | $410.22 | 554 |
| Patel, Aasita MD | $425.01 | 488 |
| Murdock, Elmer M.D. | $400.73 | 486 |
| Kakavas, Peter M.D. | $396.97 | 484 |
| Pothula, Aswartha M.D. | $411.07 | 470 |
| Trybula, Michael M.D. | $400.57 | 463 |
| Puri, Sanjeev M.D. | $410.12 | 422 |
| Singh, Param M.D. | $385.88 | 396 |
Illinois Pricing in Context
In Illinois, CPT code A9555 (Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries) carries an average Medicare payment of $568.15 — 34% above the national benchmark of $425.12. 57 providers across the state submitted claims for this procedure in 2023, performing 30.0K total services. Individual payments in IL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Illinois is $1,648.52, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Illinois sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Medical Supplies procedures, the estimated commercial insurance price in Illinois lands near $1,532.98, with self-pay cash prices typically around $988.10. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries cost in Illinois?
The average Medicare payment for Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries in Illinois is $568.15, which is 34% above the national average of $425.12. Providers in IL typically bill $1,648.52 for this procedure.
What does Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries cost with insurance in Illinois?
With commercial insurance in Illinois, Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries costs an estimated $1,532.98. Without insurance, the estimated cash price is $988.10. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries in Illinois?
57 providers in Illinois billed Medicare for Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries in 2023, performing 30.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries cheaper in Illinois than the national average?
No — Rubidium Rb-82, Diagnostic, Per Study Dose, Up To 60 Millicuries costs 34% above the national average in Illinois. The state average Medicare payment is $568.15 compared to $425.12 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.